Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV®
about
Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV®
description
clinical trial
@en
klinisch onderzoek
@nl
name
Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV®
@en
type
label
Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV®
@en
prefLabel
Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV®
@en
P4844
P1050
P1476
Safety and Efficacy With Twice ...... 0.004%/Timolol 0.5% (DUOTRAV®)
@en
P3098
NCT02730871
P580
2016-06-24T00:00:00Z
P582
2018-07-13T00:00:00Z